Business · 10/15/2026
XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation
XtalPi has nominated its first siRNA preclinical candidate for IgA Nephropathy, nine months after program initiation, with preclinical data demonstrating subnanomolar silencing potency.